The study showed that Clofazimine, a drug originally used to treat leprosy, can effectively combat new coronavirus infections in human cells and hamster models, and has a synergistic effect with Remdesivir. Clofazimine can be taken orally and has a comparatively low manufacturing cost. These characteristics make it a potentially attractive drug candidate for the new coronavirus.
